Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Soluble NKG2D Ligands in Hepatic Autoimmune Diseases and in Benign Diseases Involved in Marker Metabolism

STEFAN HOLDENRIEDER, PETER EICHHORN, ULRICH BEUERS, WALTER SAMTLEBEN, PETRA STIEBER, DOROTHEA NAGEL, ANDREA PETERFI, ALEXANDER STEINLE and HELMUT RAINER SALIH
Anticancer Research July 2007, 27 (4A) 2041-2045;
STEFAN HOLDENRIEDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Stefan.Holdenrieder{at}med.uni-muenchen.de Helmut.Salih{at}med.uni-tuebingen.de
PETER EICHHORN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ULRICH BEUERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WALTER SAMTLEBEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETRA STIEBER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOROTHEA NAGEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREA PETERFI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDER STEINLE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HELMUT RAINER SALIH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Stefan.Holdenrieder{at}med.uni-muenchen.de Helmut.Salih{at}med.uni-tuebingen.de
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 4A 2041-2045
PMID 
17649819

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 9, 2007
  • Revision received May 7, 2007
  • Accepted May 8, 2007
  • Published online July 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. STEFAN HOLDENRIEDER1,
  2. PETER EICHHORN1,
  3. ULRICH BEUERS2,
  4. WALTER SAMTLEBEN3,
  5. PETRA STIEBER1,
  6. DOROTHEA NAGEL1,
  7. ANDREA PETERFI4,
  8. ALEXANDER STEINLE5,* and
  9. HELMUT RAINER SALIH4,*
  1. 1Institute of Clinical Chemistry, University Hospital of Munich, 81377 Munich
  2. 2Medical Clinic II, University Hospital of Munich, 81377 Munich
  3. 3Medical Clinic I, University Hospital of Munich, 81377 Munich
  4. 4Department of Internal Medicine II, University Hospital of Tuebingen
  5. 5Institute for Cell Biology, Department of Immunology, Eberhard Karls University, 72076 Tuebingen, Germany
  1. Correspondence to: Stefan Holdenrieder, MD, Institute of Clinical Chemistry, University Hospital of Munich, Ludwig Maximilians University, Marchioninistr. 15, 81377 Munich, Germany. Tel: +49 89 7095 3231, Fax: +49 89 7095 6298, e-mail: Stefan.Holdenrieder{at}med.uni-muenchen.de / Helmut Salih, MD, Department of Internal Medicine II, University Hospital of Tuebingen, Otfried-Mueller Str. 10, 72076 Tuebingen, Germany. Tel: +49 7071 2982852, Fax: +49 7071 293671, e-mail: Helmut.Salih{at}med.uni-tuebingen.de

Statistics from Altmetric.com

Cited By...

  • 30 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 4A
July-August 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Soluble NKG2D Ligands in Hepatic Autoimmune Diseases and in Benign Diseases Involved in Marker Metabolism
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Soluble NKG2D Ligands in Hepatic Autoimmune Diseases and in Benign Diseases Involved in Marker Metabolism
STEFAN HOLDENRIEDER, PETER EICHHORN, ULRICH BEUERS, WALTER SAMTLEBEN, PETRA STIEBER, DOROTHEA NAGEL, ANDREA PETERFI, ALEXANDER STEINLE, HELMUT RAINER SALIH
Anticancer Research Jul 2007, 27 (4A) 2041-2045;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Soluble NKG2D Ligands in Hepatic Autoimmune Diseases and in Benign Diseases Involved in Marker Metabolism
STEFAN HOLDENRIEDER, PETER EICHHORN, ULRICH BEUERS, WALTER SAMTLEBEN, PETRA STIEBER, DOROTHEA NAGEL, ANDREA PETERFI, ALEXANDER STEINLE, HELMUT RAINER SALIH
Anticancer Research Jul 2007, 27 (4A) 2041-2045;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell Therapies
  • Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy
  • MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease
  • Google Scholar

More in this TOC Section

  • AXL Transcriptionally Up-regulates ISG15 Expression to Mediate Cell Proliferation in Non-small-cell Lung Cancer Cells
  • Inhibition of Small-cell Lung Cancer Angiogenesis by Irinotecan Metronomic Chemotherapy and Irinotecan Plus Everolimus
  • Leveraging Genome-wide Association Studies to Identify Pathogenic Variants for Breast Cancer Among Multiple Continents
Show more Experimental Studies
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire